Literature DB >> 12745049

Droperidol in the emergency department: is it safe?

John R Richards1, Aaron B Schneir.   

Abstract

Droperidol is an antipsychotic and antiemetic drug that has been used extensively by emergency physicians, psychiatrists, and anesthesiologists worldwide since 1967. It also has been used effectively for other diverse conditions, such as treatment of headache and vertigo. As of January 2001, Droperidol was no longer available in Europe after its founder, Janssen-Cilag Pharmaceuticals, discontinued its distribution. In December 2001, the United States Food and Drug Administration (FDA) placed a black box warning on the use of Droperidol in response to an association between Droperidol and fatal cardiac dysrhythmias, such as torsade de pointes, resulting from prolongation of the QT interval. In this review we closely examine the pharmacology, indications, use, and complications associated with Droperidol, and speculate on its future use in the Emergency Department.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745049     DOI: 10.1016/s0736-4679(03)00044-1

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  9 in total

Review 1.  Psychopharmacology of aggression in schizophrenia.

Authors:  Peter Buckley; Leslie Citrome; Carmen Nichita; Michael Vitacco
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 2.  Risk factors for drug-induced long-QT syndrome.

Authors:  A D C Paulussen; J Aerssens
Journal:  Neth Heart J       Date:  2005-02       Impact factor: 2.380

3.  Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management.

Authors:  Giovanni Fazio; Federica Vernuccio; Giuseppe Grutta; Giuseppe Lo Re
Journal:  World J Cardiol       Date:  2013-04-26

Review 4.  Review and management of the dental patient with Long QT syndrome (LQTS).

Authors:  Christopher Rochford; R David Seldin
Journal:  Anesth Prog       Date:  2009

5.  Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients.

Authors:  Luis Hernández-Rodríguez; Fernanda Bellolio; Daniel Cabrera; Alicia E Mattson; Derek VanMeter; Andrew E Grush; Lucas Oliveira J E Silva
Journal:  Am J Emerg Med       Date:  2021-12-22       Impact factor: 2.469

6.  The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.

Authors:  Michael P Wilson; David Pepper; Glenn W Currier; Garland H Holloman; David Feifel
Journal:  West J Emerg Med       Date:  2012-02

7.  The pharmacokinetics of intranasal droperidol in volunteers characterised via population modelling.

Authors:  Isabelle Cooper; Cornelia B Landersdorfer; Ashley Gordon St John; Andis Graudins
Journal:  SAGE Open Med       Date:  2018-12-04

8.  High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings.

Authors:  Leonie Calver; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 9.  Evidence-based review and appraisal of the use of droperidol in the emergency department.

Authors:  Pei-Chun Lai; Yen-Ta Huang
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.